Shi Du
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Molecular Biology top 10%
- RNA Interference and Gene Delivery
- Advanced biosensing and bioanalysis techniques
Papers in
-
- RNA Interference and Gene Delivery 13
- Advanced biosensing and bioanalysis techniques 5
- Lipid Membrane Structure and Behavior 3
-
- Immunotherapy and Immune Responses 5
- Immune Cell Function and Interaction 3
- Co-authors
- Yizhou Dong (15 shared papers)Xucheng Hou (14 shared papers)Jinyue Yan (13 shared papers)Binbin Deng (11 shared papers)David W. McComb (12 shared papers)Chunxi Zeng (7 shared papers)Weiyu Zhao (7 shared papers)Yonger Xue (10 shared papers)
- Journals
- Journal of Controlled Release (3 papers)Advanced Materials (3 papers)Nature Communications (2 papers)Nature Nanotechnology (2 papers)Acta Pharmaceutica Sinica B (1 paper)
- Partner nations
- United StatesChinaTaiwan
In The Last Decade
Shi Du
21 papers receiving 1.3k citations
Shi Du's Hit Papers
Peers
Comparison fields: 5 of 95
- Immunology 410
- Molecular Biology 904
- Infectious Diseases 190
- Biomaterials 134
- Oncology 179
Countries citing papers authored by Shi Du
This map shows the geographic impact of Shi Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shi Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shi Du more than expected).
Fields of papers citing papers by Shi Du
This network shows the impact of papers produced by Shi Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shi Du. The network helps show where Shi Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Shi Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 221 | |
| 2 | 2020 | 188 | |
| 3 | Intratumoral delivery of IL-12 and IL-27 mRNA using lipid nanoparticles for cancer immunotherapy Hit paper breakdown → | 2022 | 178 |
| 4 | 2020 | 151 | |
| 5 | 2020 | 114 | |
| 6 | 2021 | 88 | |
| 7 | 2023 | 66 | |
| 8 | 2023 | 62 | |
| 9 | 2023 | 59 | |
| 10 | LNP-RNA-engineered adipose stem cells for accelerated diabetic wound healing Hit paper breakdown → | 2024 | 46 |
| 11 | 2022 | 45 | |
| 12 | 2023 | 36 | |
| 13 | 2023 | 31 | |
| 14 | 2020 | 30 | |
| 15 | 2021 | 9 | |
| 16 | 2024 | 4 | |
| 17 | 2025 | 3 | |
| 18 | 2024 | 2 | |
| 19 | 2024 | 1 | |
| 20 | 2025 | 1 |
About Shi Du
Shi Du is a scholar working on Molecular Biology, Immunology, Biomaterials, Genetics and Oncology, having authored 23 papers that have together received 1.3k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (13 papers), Advanced biosensing and bioanalysis techniques (5 papers), Immunotherapy and Immune Responses (5 papers), Lipid Membrane Structure and Behavior (3 papers), Virus-based gene therapy research (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Immune Cell Function and Interaction (3 papers) and Nanoplatforms for cancer theranostics (2 papers). The work is most often cited by research in Immunology (410 citations), Molecular Biology (904 citations), Infectious Diseases (190 citations), Biomaterials (134 citations) and Oncology (179 citations). Shi Du has collaborated with scholars based in United States, China and Taiwan. Frequent co-authors include Yizhou Dong, Xucheng Hou, Jinyue Yan, Binbin Deng, David W. McComb, Chunxi Zeng, Weiyu Zhao, Yonger Xue, Wenqing Li and Xinfu Zhang. Their work appears in journals such as Journal of Controlled Release, Advanced Materials, Nature Communications, Nature Nanotechnology and Acta Pharmaceutica Sinica B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.